Orexin Receptor 2 Agonist Improves Sleepiness in Narcolepsy

THURSDAY, July 27, 2023 -- For patients with narcolepsy type 1, an orexin receptor 2 agonist, TAK-994, improves measures of sleepiness and cataplexy over eight weeks compared with placebo but is associated with hepatotoxic adverse events, according...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news